Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Conrad D, Wang A, Pieters R, Nicoletti F, Mangano K, van Heeckeren AM, White SK, Frincke JM, Reading CL, Stickney D, Auci DL.

J Inflamm (Lond). 2010 Oct 30;7:52. doi: 10.1186/1476-9255-7-52.

2.

Monitoring infection and inflammation in murine models of cystic fibrosis with magnetic resonance imaging.

Sheth VR, van Heeckeren RC, Wilson AG, van Heeckeren AM, Pagel MD.

J Magn Reson Imaging. 2008 Aug;28(2):527-32. doi: 10.1002/jmri.21440.

3.

Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium.

Perez A, van Heeckeren AM, Nichols D, Gupta S, Eastman JF, Davis PB.

Am J Physiol Lung Cell Mol Physiol. 2008 Aug;295(2):L303-13. doi: 10.1152/ajplung.90276.2008. Epub 2008 Jun 13.

4.

Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.

Teichgräber V, Ulrich M, Endlich N, Riethmüller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von Kürthy G, Schmid KW, Weller M, Tümmler B, Lang F, Grassme H, Döring G, Gulbins E.

Nat Med. 2008 Apr;14(4):382-91. doi: 10.1038/nm1748. Epub 2008 Mar 30.

5.

SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.

Grubb BR, Gabriel SE, Mengos A, Gentzsch M, Randell SH, Van Heeckeren AM, Knowles MR, Drumm ML, Riordan JR, Boucher RC.

Am J Respir Cell Mol Biol. 2006 Mar;34(3):355-63. Epub 2005 Nov 11.

6.

Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.

van Heeckeren AM, Schluchter MD, Xue W, Davis PB.

Am J Respir Crit Care Med. 2006 Feb 1;173(3):288-96. Epub 2005 Nov 4.

7.

Tissue inhibitor of metalloproteinase 1 regulates resistance to infection.

Lee MM, Yoon BJ, Osiewicz K, Preston M, Bundy B, van Heeckeren AM, Werb Z, Soloway PD.

Infect Immun. 2005 Jan;73(1):661-5.

8.

Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice.

van Heeckeren AM, Schluchter MD, Drumm ML, Davis PB.

Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L944-52. Epub 2004 Jul 9.

9.
10.

Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice.

van Heeckeren AM, Schluchter M, Xue L, Alvarez J, Freedman S, St George J, Davis PB.

Infect Immun. 2004 Mar;72(3):1479-86.

11.

Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.

Van Heeckeren AM, Scaria A, Schluchter MD, Ferkol TW, Wadsworth S, Davis PB.

Am J Physiol Lung Cell Mol Physiol. 2004 Apr;286(4):L717-26. Epub 2003 Sep 26.

12.

Murine models of chronic Pseudomonas aeruginosa lung infection.

van Heeckeren AM, Schluchter MD.

Lab Anim. 2002 Jul;36(3):291-312.

PMID:
12144741
13.

Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice.

Mhanna MJ, Ferkol T, Martin RJ, Dreshaj IA, van Heeckeren AM, Kelley TJ, Haxhiu MA.

Am J Respir Cell Mol Biol. 2001 May;24(5):621-6.

PMID:
11350833
14.

Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice.

van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, Erokwu B, Haxhiu MA, Ferkol TW.

Am J Respir Crit Care Med. 2000 Jan;161(1):271-9.

PMID:
10619831

Supplemental Content

Loading ...
Support Center